Last Posted: Dec-23-2016 2PM
From CDC Information Database
This database includes general CDC public health information on specific diseases and health related topics. When available, the database displays genomic information from various CDC web pages. Users are also encouraged to conduct searches of CDC website for additional information.
- CDC Medscape Expert Commentary: Genetics and BRCA in Primary Care
by Katherine Kolor, Medscape, October 13, 2014 - CDC Information: Share Your Story. Empower and Educate Young Women
About 11% of new breast cancer cases in the United States affect women under the age of 45, but many young women may not realize they are at risk for this disease. - Knowing BRCA Changed My Life
By Debbie Wasserman Schultz, CDC Blog Post 2014 - CDC Know:BRCA Tool
Some women carry certain genetic changes in their BRCA genes that increase their risks for getting breast, ovarian, and other kinds of cancers at a young age
From CDC-Authored Genomics Publication Database
This database contains CDC-authored publications in public health genomics including infectious diseases, newborn screening, reproductive health, genetic testing, cancer, chronic diseases, birth defects and developmental disabilities, environmental and occupational health as well as laboratory, bioinformatics and statistical methods.
- Prevalence and healthcare actions of women in a large health system with a family history meeting the 2005 USPSTF recommendation for BRCA genetic counseling referral.
Bellcross Cecelia A et al. Cancer Epidemiol. Biomarkers Prev. 2013 Apr 22(4) 728-35 - Reported referral for genetic counseling or BRCA 1/2 testing among United States physicians: a vignette-based study.
Trivers Katrina F et al. Cancer 2011 Dec 1. 117(23) 5334-43
From Implementation Database
This database focuses on state and national activities that integrate genomics into public health programs and clinical practice
- BRCA Patient - Spanish version 2016
[Disease: Breast Cancer|Ovarian Cancer; Type: Education; State: Multiple States] - http://www.mdedge.com/jcso/article/110048/gynecologic-cancer/hereditary-breast-and-ovarian-cancer-risk-assessment-minority
[Disease: Breast Cancer|Ovarian Cancer; Type: Data|Program; State: Georgia] - The Activities and Impact of State Programs to Address Hereditary Breast and Ovarian Cancer, 2011–2014
[Disease: Breast Cancer|Ovarian Cancer; Type: Multipe Types; State: Georgia|Michigan|Oregon] - FORCE family letter for BRCA1 and BRCA2 carriers[PDF 64.08 KB]
[Disease: Breast Cancer|Ovarian Cancer; Type: Tools; State: Multiple States] - FORCE Letter to Relatives about Genetic Mutation[PDF 64.05 KB]
[Disease: Breast Cancer|Ovarian Cancer; Type: Tools; State: Multiple States]
From Guideline Database
This database contains updated guidelines, policies and recommendations on genomic research and practice, as provided by professional organizations, federal advisory groups, expert panels and policy groups.
- SEOM clinical guidelines in Hereditary Breast and ovarian cancer.
Published 2015 (Sociedad Espanola de Oncologia Medica (SEOM)) - Clinical Practice Guideline for the prevention and early detection of breast and ovarian cancer in women from HBOC (hereditary breast and ovarian cancer) families.
Published 2015 (Expert panel) - BRCA1 and BRCA2 genetic testing-pitfalls and recommendations for managing variants of uncertain clinical significance.
Published 2015 (Clinical Working Group of ENIGMA) - BRCA1 and BRCA2 genetic testing - pitfalls and recommendations for managing variants of uncertain clinical significance.
Published 2015 (Evidence-based Network for the Interpretation of Germline Mutant Alleles (ENIGMA) Clinical Working Group) - Screening for ovarian cancer: U.S. Preventive Services Task Force reaffirmation recommendation statement.
Published 2012 (US Preventive Services Task Force)
From Tier Table Database
CDC Office of Public Health Genomics (OPHG) conducts horizon scanning (a systematic research method to find and follow novel technologies appearing in the literature) to identify and track the progress of genomic tests as they move from research into clinical and public health practice. As an aid in organizing horizon scanning results, OPHG ranks genomic tests, and family health history applications, by levels of evidence. See detail.
| Disease/Disorder | Test to be Assessed | Intended Use | Tier Classified | Detail |
|---|---|---|---|---|
| Hereditary breast/ovarian cancer | Routine BRCA genetic counseling, routine BRCA testing | Population screening | Tier 3  | |
| Hereditary breast and ovarian cancer | Family history of known breast/ovarian cancer with deleterious BRCA mutation | Risk prediction; referral to counseling for BRCA genetic testing | Tier 1 | |
| BRCA-related cancer; hereditary breast and ovarian cancer | Family history | Risk prediction for referral for BRCA genetic counseling | Tier 1 |
From HuGE Literature Finder Database
This database contains published literature on genetic associations and other human genome epidemiology
- Bilateral Oophorectomy and Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers.
Journal of the National Cancer Institute 2017 Jan 109 (1): .
Kotsopoulos Joanne, Huzarski Tomasz, Gronwald Jacek, Singer Christian F, Moller Pal, Lynch Henry T, Armel Susan, Karlan Beth, Foulkes William D, Neuhausen Susan L, Senter Leigha, Tung Nadine, Weitzel Jeffrey N, Eisen Andrea, Metcalfe Kelly, Eng Charis, Pal Tuya, Evans Gareth, Sun Ping, Lubinski Jan, Narod Steven A, - Effect of Itraconazole and Rifampin on the Pharmacokinetics of Olaparib in Patients With Advanced Solid Tumors: Results of Two Phase I Open-Label Studies.
Clinical therapeutics 2016 Oct .
Dirix Luc, Swaisland Helen, Verheul Henk M W, Rottey Sylvie, Leunen Karin, Jerusalem Guy, Rolfo Christian, Nielsen Dorte, Molife L Rhoda, Kristeleit Rebecca, Vos-Geelen Judith de, Mau-Sørensen Morten, Soetekouw Patricia, van Herpen Carla, Fielding Anitra, So Karen, Bannister Wendy, Plummer Ru - Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer.
The New England journal of medicine 2016 Oct .
Mirza Mansoor R, Monk Bradley J, Herrstedt Jørn, Oza Amit M, Mahner Sven, Redondo Andrés, Fabbro Michel, Ledermann Jonathan A, Lorusso Domenica, Vergote Ignace, Ben-Baruch Noa E, Marth Christian, M?dry Rados?aw, Christensen René D, Berek Jonathan S, Dørum Anne, Tinker Anna V, du Bois Andreas, González-Martín Antonio, Follana Philippe, Benigno Benedict, Rosenberg Per, Gilbert Lucy, Rimel Bobbie J, Buscema Joseph, Balser John P, Agarwal Shefali, Matulonis Ursula A, - Outcome of ovarian cancer after breast cancer in BRCA1 and BRCA2 mutation carriers.
British journal of cancer 2016 Oct .
Zaaijer Leendert H, van Doorn Helena C, Mourits Marian J E, van Beurden Marc, de Hullu Joanne A, Adank Muriel A, van Lonkhuijzen Luc R C W, Vasen Hans F A, Slangen Brigitte F M, Gaarenstroom Katja N, Zweemer Ronald P, Vencken Peggy M L H, Seynaeve Caroline, Kriege Mie - Triple negative breast cancer in North of Morocco: clinicopathologic and prognostic features.
BMC women's health 2016 Oct 16 (1): 68.
Derkaoui Touria, Bakkach Joaira, Mansouri Mohamed, Loudiyi Ali, Fihri Mohamed, Alaoui Fatima Zahra, Barakat Amina, El Yemlahi Bouchra, Bihri Hassan, Nourouti Naima Ghailani, Mechita Mohcine Benna
No hay comentarios:
Publicar un comentario